Zillow Group(Z)
搜索文档
Zillow Upgraded, Analyst Predicts Strong Growth With Lower Mortgage Rates On The Horizon
Benzinga· 2024-09-17 03:03
Zillow Group, Inc. Z shares are trading higher after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $50 to $80.The analyst Jay McCanless writes they see a potential boost from lower mortgage rates for Zillow’s core brokerage business.The S&S revenues, included in the Residential revenue line, have contributed to faster revenue growth compared to the national existing home market in recent quarters, adds the analyst.McCanless maintained third-quarter estimates, which a ...
Zillow Poised To Reap Benefits of Lower Mortgage Rates, Wedbush Says
Investopedia· 2024-09-17 02:11
文章核心观点 - 摩根大通分析师认为,Zillow集团(Zillow Group)有望从美国房贷利率下降中获益[1] - Zillow集团股价自8月初新任CEO上任以来已上涨约50%[1] - 分析师看好Zillow集团的软件和服务(S&S)业务[2] 摩根大通分析师观点总结 - 美国30年期房贷利率从2024年4月的高点7.52%下降至6.03%[2] - Zillow集团的软件和服务(S&S)业务是潜在的增长动力[2] - 分析师预计Zillow集团的S&S工具使用将增加,因为经纪人希望降低人工成本[2] - 4位分析师中有2位给予"买入"评级,2位给予"持有"评级,平均目标价为57.50美元[2]
Real Estate Stock Soars on Upgrade, Rate-Cut Buzz
Schaeffers Investment Research· 2024-09-16 22:50
Zillow Group Inc (NASDAQ:Z) is one of the best stocks on the Nasdaq this morning, last seen up 3.2% to trade at $61.58, and earlier hitting a new two-year high of $61.71. The real estate services stock was upgraded to "outperform" from "neutral" by Wedbush, and the firm also threw in a hefty price-target hike to $80 from $50. The analyst in coverage noted falling mortgage rates -- last seen at 6.1% -- and lower borrowing costs hopefully ahead as the Federal Reserve cuts interest rates. Z has now built some ...
Zillow Group Inc. (Z) Presents at Goldman Sachs Communacopia + Technology Conference (Transcript)
Seeking Alpha· 2024-09-10 22:52
Zillow Group Inc. (NASDAQ:Z) Goldman Sachs Communacopia + Technology Conference September 9, 2024 6:45 PM ET Company Participants Jeremy Hofmann - Chief Financial Officer Conference Call Participants Mike Ng - Goldman Sachs Mike Ng Great. Well, thank you, everybody. Welcome to the Zillow fireside chat at the Goldman Sachs Communacopia + Technology Conference. I have the privilege of introducing Jeremy Hofmann, who's the CFO of Zillow. Prior to joining Zillow in 2017, Jeremy was at Goldman Sachs Investment B ...
Zillow Group Inc. (Z) Presents at Goldman Sachs Communacopia + Technology Conference (Transcript)
2024-09-10 22:52
会议主要讨论的核心内容 - 公司在当前艰难的美国房地产市场背景下仍能保持双位数收入增长和适度EBITDA利润率扩张 [3][4] - 公司应对全国房地产经纪人协会(NAR)结算的影响,认为这对消费者和行业都是积极变化 [6][7][8] - 公司在流量和品牌方面的竞争优势,拥有约70%的市场份额和3倍于竞争对手的应用程序用户 [10][11][12] - 公司正在扩展"增强市场"战略,提升客户和经纪人体验,预计将在10月底前覆盖43个市场 [25][26] - 公司租赁业务持续高速增长,未来有望达到10亿美元收入规模 [28][29][32] - 公司自有贷款业务增长迅速,未来将通过增强市场、内部推广等方式进一步提升市场份额 [37][38][39][40] 问答环节重要的提问和回答 - 分析师询问公司如何在艰难的房地产市场背景下保持强劲的收入增长和利润率扩张,公司表示通过新业务投资和成本管控来实现 [3][4] - 分析师询问NAR结算对公司Premier Agent业务的影响,公司认为影响将是渐进式而非革命性的,并表示有竞争优势应对变化 [6][7][8] - 分析师询问公司在流量和品牌方面的竞争优势,公司表示拥有约70%的市场份额和3倍于竞争对手的应用程序用户 [10][11][12] - 分析师询问公司"增强市场"战略的进展和意义,公司表示将在10月底前覆盖43个市场,提升客户和经纪人体验 [25][26] - 分析师询问公司租赁业务的发展情况和前景,公司表示未来有望达到10亿美元收入规模 [28][29][32] - 分析师询问公司自有贷款业务的增长动力,公司表示将通过增强市场、内部推广等方式进一步提升市场份额 [37][38][39][40]
Zillow (ZG) Up 9% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-09-07 00:37
文章核心观点 - 公司在第二季度业绩表现良好,营收和利润均超出预期 [2][3] - 公司的住宅和租赁业务表现强劲,带动了整体营收增长 [4] - 公司的贷款业务也有所增长,但受到部分抵消 [5] - 公司的现金流和流动性状况良好 [7][8] - 公司对第三季度和全年的业绩预期较为乐观 [9] 根据目录分类总结 财务数据 - 第二季度净亏损1700万美元,非GAAP净利润9900万美元,每股收益0.39美元 [3] - 第二季度营收5.72亿美元,同比增长13% [4] - 住宅业务收入4.09亿美元,同比增长8% [4] - 租赁业务收入1.17亿美元,同比增长29% [4] - 贷款业务收入3400万美元,同比增长42% [5] - 毛利率为77%,同比下降2个百分点 [6] - 经营活动产生的现金流量为1.35亿美元 [7] - 现金及现金等价物余额为11.81亿美元 [8] 业务发展 - 公司在住宅和租赁业务方面保持强劲增长 [4] - 公司的技术产品如实时看房、展示页面、客户关系管理等受到市场欢迎 [2] - 公司对第三季度和全年的业绩预期较为乐观,预计将实现双位数收入增长 [9] 行业动态 - 公司所属的互联网服务行业整体表现良好,同行企业DoorDash也实现了较好的业绩 [13]
Zillow Group Boosts AI-Powered Search Experience: Stock to Gain?
ZACKS· 2024-09-06 01:11
Zillow Group, Inc. (ZG) recently announced that it has upgraded its AI-powered search engine capabilities. The new version offers greater freedom and personalization, enabling buyers and renters to search properties using simple and everyday natural language.Leveraging advanced AI and machine learning models, Zillow has transformed its search engine to respond in a friendly conversational manner with natural and human-like sentences. Home buyers often have a wide range of criteria when they look for their i ...
Zillow Group to present at Goldman Sachs Communacopia + Technology Conference
Prnewswire· 2024-09-04 04:05
SEATTLE, Sept. 3, 2024 /PRNewswire/ -- Zillow Group, Inc. (Nasdaq: Z and ZG), which is transforming the way people buy, sell, rent and finance homes, today announced that it will present at the Goldman Sachs Communacopia + Technology Conference on Sept. 9, 2024.Zillow Group CFO Jeremy Hofmann will participate in a fireside chat, moderated by Goldman Sachs' Michael Ng, at 3:45 p.m. PST/6:45 p.m. EST on Monday, Sept. 9. Both live and recorded versions of the webcast will be available under the Events & Presen ...
Zillow Data Offers Rental Upgrade Insights: Beneficial for ZG Stock?
ZACKS· 2024-08-29 21:46
文章核心观点 - 房地产公司Zillow Group(ZG)通过分析约560万套出租房的数据,发现了Millennials和Gen Z成人喜欢的一些经济实惠的临时性租房装修方式 [1][2][3] - 这些装修方式不仅能让租户个性化居住空间,也能为房东带来收益,是一种双赢的情况 [2] - Zillow的研究显示,一些简单的装修如加装开放式置物架、智能照明等,能大幅提高租房信息的浏览量和分享量 [2] - 这些装修项目成本较低,大多在1000美元以内,对大多数租户来说都是可承担的 [3] - Zillow希望通过提供这些数据洞见,巩固自己在租房市场的领导地位,并优化营销策略以满足租户的需求 [4] 行业分析 - 行业整体呈现良好发展态势,Zillow目前评级为买入评级 [5] - 同行Arista Networks(ANET)和AudioCodes(AUDC)也获得了买入评级,预计未来业绩表现良好 [5][6] - 另一家公司Airgain(AIRG)也获得了买入评级,长期盈利增长预期35% [7]
Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer
GlobeNewswire News Room· 2024-08-21 20:30
SEATTLE, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ (QLHC), today announced the first patient has been dosed in their clinical trial evaluating Atossa’s proprietary (Z)-endoxifen in combination with abemaciclib (VERZENIO®), a cyclin-dependent kinase (CDK) 4/6 inhibitor marketed by Eli Lilly and Company, as a neoadjuvant treatment in high-risk women with newly diagnosed Estrogen Receptor positive (ER+) / Hu ...